Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Scarlet Fu on these topics and the impact of tariffs.

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year. During a CNBC interview, Narasimhan emphasized the company’s strong fundamentals, pointing to 10 consecutive quarters of raised guidance and robust financial performance.

The imposition of tariffs on pharmaceutical imports—either directly or indirectly through raw materials and active pharmaceutical ingredients (APIs)—can profoundly impact drug prices ...

But the impact of the tariff would likely go beyond its immediate costs. A pharmaceutical tariff could disrupt the world’s drug supply chain, discouraging companies from importing both finished ...

How might the healthcare landscape be impacted by tariffs? ... Will Trump Tariffs Impact Drug Prices and Healthcare Stocks? April 03, 2025 — 04:30 pm EDT.

So, tariffs may have a larger impact there. Not only that, but the generics Marketplace is a thin margin marketplace, so you could even see perhaps a curtailment of some supply as manufacturers decide they're not going to manufacture certain drugs that require increasing prices and raw materials that they can't pass on to the consumer.

Will Trump Tariffs Impact Drug Prices and Healthcare Stocks? Motley Fool YouTube, The Motley Fool. April 3, 2025 at 4:30 PM. Copied; How might the healthcare landscape be impacted by tariffs?